Home › Funds › Ikarian Capital, LLC › PHVS

Ikarian Capital, LLC position in PHVS

PHARVARIS N V · Health Care

Ikarian Capital, LLC reported holding 308,856 shares of PHVS (PHARVARIS N V) in its Q2 2026 13F filing — a position valued at US$10.7M, representing 1.72% of its reported portfolio and ranking #17 among its reported holdings. Ikarian Capital, LLC has disclosed PHVS holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)308.86K sh
Reported value held$10.68M
Portfolio Weight1.72%
First reportedQ3 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Ikarian Capital, LLC's PHVS position evolved

Ikarian Capital, LLC first disclosed a stake in PHVS in Q3 2025 at 210,165 shares (US$5.2M). The position peaked in Q1 2026 at 486,856 shares, worth US$13.8M. Across 4 filings, Ikarian Capital, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 308,856 shares valued at US$10.7M — a reduction of -178,000 shares quarter over quarter.. Notable position changes include a 132% increase in Q4 2025 (shares rose 2% over the following quarter), a 37% trim in Q2 2026 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 210.16K $5.24M New
Q4 2025 486.86K $13.51M Add
Q1 2026 486.86K $13.75M Hold
Q2 2026 308.86K $10.68M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PHVS and 13F data

PHVS (PHARVARIS N V) is a Health Care company. 49 other funds we track also report a position in PHVS — the largest reported positions include GENERAL ATLANTIC, L.P. (US$226.5M), Foresite Capital Management IV, LLC (US$165.2M), venBio Partners LLC (US$160.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PHVS

All PHVS fund holders →

FAQ

How long has Ikarian Capital, LLC held PHVS?

Ikarian Capital, LLC has disclosed PHVS holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Ikarian Capital, LLC's current position in PHVS?

As of Q2 2026, Ikarian Capital, LLC holds 308.86K shares of PHVS (PHARVARIS N V), valued at $10.68M, representing 1.72% of its reported portfolio and ranking #17.

Has Ikarian Capital, LLC been buying or selling PHVS?

In the latest 13F filing (Q2 2026), Ikarian Capital, LLC reduced its position in PHVS. The position peaked in Q1 2026 at 486.86K shares.

Which other funds hold PHVS?

Other major institutional holders of PHVS include GENERAL ATLANTIC, L.P., Foresite Capital Management IV, LLC, venBio Partners LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.